More on AKTX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.25 |
|
|||
| Open | $0.24 | ||||
| 52 Wk High | $19.75 | ||||
| 52 Wk Low | $7.63 | ||||
| Day High | $0.26 | ||||
| Day Low | $0.24 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 153,494 | ||||
- Akari Therapeutics adds cancer expert Prafulla Gokhale to advisory board
- Akari Therapeutics Appoints Leading Cancer Biology and RNA Expert, Prafulla Gokhale, Ph.D., to Scientific Advisory Board
- Akari Therapeutics adds RNA biology expert to advisory board
- Akari Therapeutics Appoints Globally Recognized Expert in RNA Biology and Cancer Research, Olga Anczukow, Ph.D., to its Scientific Advisory Board
- Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
- Akari Therapeutics to Present at the 2026 Biocom Global Partnering & Investor Conference
- Akari Therapeutics Releases New CEO Corner Segment Highlighting 2025 Progress and Path to Clinical Transition In 2026
- Akari Therapeutics to Present at the 2026 Biotech Showcase
- Ladenburg Thalmann Starts Akari Therapeutics (AKTX) at Buy
- Akari Therapeutics outlines 2025 progress in shareholder letter
Entities mentioned with AKTX
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Dividend | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- Show More...
